Biofrontera Inc. provided revenue guidance for the fourth quarter and full year ended December 31, 2022. For the quarter, the company anticipated revenue to be in the range of approximately $10.2 million to $10.4 million, an increase of approximately 12% compared with the fourth quarter of 2021.
For the full year, the company expected revenue of approximately $28.7 million to $28.9 million, a record high and up approximately 20% compared with 2021.